The approval process for generic drugs involves a thorough evaluation by regulatory bodies like the FDA. Manufacturers must submit an Abbreviated New Drug Application (ANDA) demonstrating that the generic drug is bioequivalent to the brand-name drug. This includes extensive testing on the drug's chemical composition, manufacturing process, and stability.
